Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2023-08-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于对外投资暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding the progress of an external investment and related party transaction involving an increase in the fund size of a private equity fund and the company's increased capital commitment. It includes details about the fund's registration, partners, and capital contributions. The document is relatively short (1108 characters) and serves as an update on investment and related party transaction progress rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2023-08-30 Chinese
2023年半年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (319 characters) indicating that the company's 2023 semi-annual report has been published and is available on official websites. It does not contain the actual financial data or report content but serves as a notification for investors to review the report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about report availability is classified as a Report Publication Announcement (RPA).
2023-08-25 Chinese
中国银河证券股份有限公司关于天津瑞普生物技术股份有限公司使用闲置自有资金购买理财产品的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from China Galaxy Securities regarding Tianjin Ruipu Biotechnology Co., Ltd.'s use of idle funds to purchase financial products. It includes descriptions of the investment purpose, types, limits, risk analysis, internal approvals, and independent opinions. It is not a financial report like an annual or interim report, nor is it a simple announcement. It is a verification or audit-type report related to a specific financial activity, prepared by a sponsor or auditor. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial matters. The document is 2738 characters, which is too long and detailed to be a mere announcement (RPA) or regulatory filing (RNS). Therefore, the best classification is AR with high confidence. Q3 2023
2023-08-25 Chinese
2023年半年度募集资金存放与使用情况专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage and usage of funds raised by the company during the half-year period of 2023. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. The content includes specifics on the amount raised, usage during the reporting period, balances, storage in special accounts, investment projects funded by the raised capital, and compliance with regulatory requirements. The document is titled as a "2023 Half-Year Special Report on the Storage and Use of Raised Funds" and contains substantive financial data and analysis related to the use of capital raised through a specific stock issuance. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an announcement of a report publication, nor a general regulatory filing, but a detailed report on the use of raised funds for a specific period. Therefore, the appropriate classification is CAP.
2023-08-25 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the company's fifth board of directors' seventh meeting. It includes information about the approval of the 2023 half-year report and its summary, approval of a special report on the use of raised funds, decisions on using idle funds for financial products, adjustments to a restricted stock incentive plan, and the scheduling of a shareholders' meeting. The document contains no actual financial statements or detailed financial data but rather reports on board decisions and approvals. It is not the half-year report itself but an announcement of board meeting resolutions related to various corporate governance and financial management matters. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 2784 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full financial report.
2023-08-25 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2023 Half-Year Report Summary' (半年度报告摘要) for Tianjin Ringpu Biotechnology Co., Ltd. It contains detailed financial data for the half-year period, including revenue, net profit, cash flow, earnings per share, and asset information. It also includes shareholder information and notes on changes in controlling shareholders, which are typical components of an interim or quarterly financial report. The document length is 2435 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.